共 10 条
[1]
Aspirin resistance: clinical significance and genetic polymorphism. Xu Z-H,Jiao J-R,Yang R,Luo B-Y,Wang X-F,Wu F. The Journal of international medical research . 2012
[2]
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Mega Jessica L,Close Sandra L,Wiviott Stephen D,Shen Lei,Walker Joseph R,Simon Tabassome,Antman Elliott M,Braunwald Eugene,Sabatine Marc S. The Lancet . 2010
[3]
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Sim Sarah C,Risinger Carl,Dahl Marja-Liisa,Aklillu Eleni,Christensen Magnus,Bertilsson Leif,Ingelman-Sundberg Magnus. Clinical Pharmacokinetics . 2006
[4]
Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting. Heleen J. Bouman,Ankie M. Harmsze,Jochem W. van Werkum. Heart . 2011
[5]
Aspirin plus clopidogrel in acute minor ischaemic stroke or transient ischaemic attack is superior to aspirin alone for stroke risk reduction:CHANCE trial. Gorelick PB,Farooq MU. Evid Based Med . 2014
[6]
Paraoxonase-1 is a major determinant of clopidogrel efficacy. Heleen J Bouman,Edgar Sch?mig,Jochem W van Werkum,Janna Velder,Christian M Hackeng,Christoph Hirschh?user,Christopher Waldmann,Hans-Günther Schmalz,Jurri?n M ten Berg,Dirk Taubert. Nature Medicine . 2010
[7]
Impact of P-glycoprotein on clopidogrel absorption. Dirk Taubert,Nicolas von Beckerath,Gundula Grimberg,Andreas Lazar,Norma Jung,Tobias Goeser,Adnan Kastrati,Albert Sch?mig,Edgar Sch?mig. Clinical Pharmacokinetics . 2006
[8]
Cytochrome p-450 polymorphisms and response to clopidogrel. Mega Jessica L,Close Sandra L,Wiviott Stephen D,Shen Lei,Hockett Richard D,Brandt John T,Walker Joseph R,Antman Elliott M,Macias William,Braunwald Eugene,Sabatine Marc S. The New England Quarterly . 2008
[9]
Cyclooxygenase Polymorphisms and Risk of Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Study. C R Lee,K E North,M S Bray,D J Couper,G Heiss,D C Zeldin. Clinical Pharmacokinetics . 2007
[10]
The Cyclooxygenase-1 C50T Polymorphism Is Not Associated with Aspirin Responsiveness Status in Stable Coronary Artery Disease in Tunisian Patients. Tahar Chakroun,Faouzi Addad,Saloua Yacoub. GENETIC TESTING AND MOLECULAR BIOMARKERS . 2011